Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Equillium Inc. buy geldnutzer

Equillium Inc.
Start price
€3.82
21.12.20 / 50%
Target price
€6.00
21.12.21
Performance (%)
3.14%
End price
€3.94
20.12.21
Summary
This prediction ended on 20.12.21 with a price of €3.94. With a performance of 3.14%, the BUY prediction by geldnutzer for Equillium Inc. closed with a slight gain. geldnutzer has a follow-up prediction for Equillium Inc. where he still thinks Equillium Inc. is a Buy. geldnutzer has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Equillium Inc. - - - -
iShares Core DAX® 0.160% -1.640% 12.016% 15.557%
iShares Nasdaq 100 -3.020% -4.715% 37.102% 42.685%
iShares Nikkei 225® -2.519% -7.621% 18.066% 2.904%
iShares S&P 500 -1.377% -2.809% 26.536% 41.689%

According to geldnutzer what are the pros and cons of Equillium Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
Capable Management
Good culture
Innovative
Small cyclical dependencies
Future proof or reliable business model
Cons
Risky balance sheet
High valuation
Very low/no dividend yield expected
Bad rating
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is not important
high free float
Below average Marketposition
Little known brand
Lower EBIT Margin than peer group
negative Cash Flow expected
Higher risks for its business

Comments by geldnutzer for this prediction

In the thread Equillium Inc. diskutieren
Prediction Buy
Perf. (%) 3.14%
Target price 4.500
Change
Ends at 21.12.21

Buy mit Kursziel 4,5

geldnutzer 
0
Report Share
21.12.20
Prediction Buy
Perf. (%) 3.14%
Target price
Change
Ends at 21.12.21

Kursziel geändert auf 0,0

geldnutzer 
0
Report Share
24.01.21
Prediction Buy
Perf. (%) 3.14%
Target price 6.000
Change
Ends at 21.12.21

Kursziel gesetzt auf 6,0

geldnutzer 
0
Report Share
26.01.21
Prediction Buy
Perf. (%) 3.14%
Target price 9.000
Change
Ends at 21.12.21

Kursziel geändert auf 9,0

geldnutzer 
0
Report Share
20.02.21
Prediction Buy
Perf. (%) 3.14%
Target price 7.000
Change
Ends at 21.12.21

Kursziel geändert auf 7,0

geldnutzer 
0
Report Share
19.04.21
Prediction Buy
Perf. (%) 3.14%
Target price 6.000
Change
Ends at 21.12.21

Kursziel geändert auf 6,0

geldnutzer 
0
Report Share
10.07.21
In the thread Trading Equillium Inc.
Prediction Sell
Perf. (%) 3.14%
Target price 6.000
Change
Ends at 21.12.21

Buy beendet

geldnutzer 
0
Report Share
20.12.21

Current prediction by geldnutzer for Equillium Inc.

buy
Equillium Inc.

Start price
Target price
Perf. (%)
€0.64
24.06.23
€1.10
24.06.24
137.81%
19.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
24.06.23 50%

Stopped prediction by geldnutzer for Equillium Inc.

sell
Equillium Inc.

Start price
Target price
Perf. (%)
€0.52
11.03.23
€0.70
11.03.24
22.72%
24.06.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
11.03.23 50%
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€2.33
03.10.22
€1.50
03.10.23
-77.66%
11.03.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
03.10.22 50%
sell
Equillium Inc.

Start price
Target price
Perf. (%)
€2.81
12.04.22
€2.00
12.04.23
-16.82%
03.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
12.04.22 50%
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€3.45
24.01.22
€4.00
24.01.23
-18.71%
12.04.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
24.01.22 50%
sell
Equillium Inc.

Start price
Target price
Perf. (%)
€3.94
20.12.21
€3.00
20.12.22
-12.39%
24.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
20.12.21 50%
sell
Equillium Inc.

Start price
Target price
Perf. (%)
€4.02
10.12.20
€3.50
10.12.21
-4.98%
21.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
10.12.20 50%
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€4.42
23.11.20
€5.50
23.11.21
-9.05%
10.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
23.11.20 50%
sell
Equillium Inc.

Start price
Target price
Perf. (%)
€10.70
27.07.20
€3.50
04.11.21
-58.69%
23.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
27.07.20 50%
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€12.50
13.07.20
€16.00
27.07.20
-14.40%
27.07.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
geldnutzer 
13.07.20 50%